DV
Dividend Vision

CHRS — Coherus BioSciences Inc

Coherus BioSciences Inc (CHRS)

Total return is -90.5% over the past 11.8 years, 455.7 points behind SPY at 365.2%. Its deepest 1-year drawdown was 54.6%.

This is a single-stock equity holding in Coherus BioSciences Inc, a biopharmaceutical company, rather than a diversified ETF. The holding does not currently pay dividends, resulting in no distribution rate or yield profile. With no distribution frequency, expense ratio data, or assets under management available, this appears to be an atypical listing that may warrant verification, as it functions more like a direct stock position than a traditional dividend-focused ETF.

CHRS key facts

Asset type
Stock
Asset class
Equity
Inception date
11/06/2014
Last close
$1.20
Market cap
$215,949,856
Average volume
647100.0
Beta
0.979
Payout ratio
0.0
Forward P/E
41.1523
EPS
$-1.42